1. Home
  2. THS vs NRIX Comparison

THS vs NRIX Comparison

Compare THS & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THS
  • NRIX
  • Stock Information
  • Founded
  • THS 2021
  • NRIX 2009
  • Country
  • THS United States
  • NRIX United States
  • Employees
  • THS N/A
  • NRIX N/A
  • Industry
  • THS Packaged Foods
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • THS Consumer Staples
  • NRIX Health Care
  • Exchange
  • THS Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • THS 863.0M
  • NRIX 750.4M
  • IPO Year
  • THS N/A
  • NRIX 2020
  • Fundamental
  • Price
  • THS $19.41
  • NRIX $9.82
  • Analyst Decision
  • THS Hold
  • NRIX Strong Buy
  • Analyst Count
  • THS 6
  • NRIX 14
  • Target Price
  • THS $23.67
  • NRIX $28.14
  • AVG Volume (30 Days)
  • THS 1.1M
  • NRIX 1.2M
  • Earning Date
  • THS 11-11-2025
  • NRIX 10-09-2025
  • Dividend Yield
  • THS N/A
  • NRIX N/A
  • EPS Growth
  • THS N/A
  • NRIX N/A
  • EPS
  • THS 0.40
  • NRIX N/A
  • Revenue
  • THS $3,334,800,000.00
  • NRIX $83,687,000.00
  • Revenue This Year
  • THS $1.61
  • NRIX $78.20
  • Revenue Next Year
  • THS $1.12
  • NRIX N/A
  • P/E Ratio
  • THS $48.33
  • NRIX N/A
  • Revenue Growth
  • THS N/A
  • NRIX 48.32
  • 52 Week Low
  • THS $15.85
  • NRIX $8.18
  • 52 Week High
  • THS $42.48
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • THS 51.79
  • NRIX 52.20
  • Support Level
  • THS $18.53
  • NRIX $9.00
  • Resistance Level
  • THS $20.11
  • NRIX $10.85
  • Average True Range (ATR)
  • THS 0.95
  • NRIX 0.68
  • MACD
  • THS -0.06
  • NRIX 0.12
  • Stochastic Oscillator
  • THS 25.48
  • NRIX 60.75

About THS Treehouse Foods Inc.

TreeHouse Foods is the largest pure-play private-label manufacturer in the US. Much larger in the past following the 2016 acquisition of Ralcorp, Conagra's former private-label business, the company has since divested several businesses to focus on high-growth categories. At present, the company produces and sells snacks (crackers, pretzels, cookies, and so on), beverages (such as nondairy creamer, coffee, tea, broth), and a select number of grocery products (pickles, refrigerated dough, hot cereal, cheese, and pudding). Its most important sales channel is through retail grocery stores that sell its products under their own brands, with co-manufacturing and food away from home as much smaller channels of distribution for its fare.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: